Clinical Trial Update: Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Takeda's TAK-559 Phase 3 trial for Type 2 diabetes mellitus has been terminated. No efficacy results are reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TAK-559

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: TERMINATED